Moderna Inc. (NasdaqGS: MRNA) surged Monday after the company’s Covid-19 vaccine was granted a provisional adult authorization in Australia, lifting biotechnology sector-related exchange traded funds. On Monday, the VanEck Vectors Biotech ETF (BBH) rose 3.0% and the iShares Nasdaq...